SynthesisClinical pharmacokinetics2025

Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review.

Femke A Elzinga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.